Depot-medroxyprogesterone acetate: an update

@article{Bakry2007DepotmedroxyprogesteroneAA,
  title={Depot-medroxyprogesterone acetate: an update},
  author={S. Bakry and Z. Merhi and T. Scalise and M. Mahmoud and A. Fadiel and F. Naftolin},
  journal={Archives of Gynecology and Obstetrics},
  year={2007},
  volume={278},
  pages={1-12}
}
ObjectiveDepo-Provera® is a contraceptive approved by the US Food and Drug Administration (FDA) since 1992 and used worldwide by more than 90 million women.Aim of studyDespite the fact that progestins are endogenous hormones that are secreted by the body, its excess might lead to detrimental health effects. Whether progestins as contraceptives are friends or foes is a questionable matter. In this manuscript, we drive the attention to both usage and side effects Depo-Provera.ResultsDepot… Expand
Parenteral Toxicity of Medroxyprogesterone Acetate
Depo-medroxyprogesterone acetate, weight gain and amenorrhea among obese adolescent and adult women
...
1
2
3
4
...

References

SHOWING 1-10 OF 112 REFERENCES
Long-acting injectable contraception with depot medroxyprogesterone acetate.
  • A. Kaunitz
  • Medicine
  • American journal of obstetrics and gynecology
  • 1994
Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer.
  • A. Kaunitz
  • Medicine
  • The Journal of reproductive medicine
  • 1996
Toxicology of depot medroxyprogesterone acetate.
Medroxyprogesterone Acetate Therapy in Early Pregnancy Has No Apparent Fetal Effects
Depo-provera associated with weight gain in Navajo women.
Effect of depot medroxyprogesterone acetate and testosterone oenanthate on serum lipoproteins in man.
...
1
2
3
4
5
...